e-learning
resources
London 2016
Tuesday, 06.09.2016
Immune responses in the lung
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Dysregulation of type 2 innate lymphoid cells and Th2 cells impairs pollutant-induced allergic airway responses
Katrien De Grove (Ghent, Belgium), Katrien De Grove, Sharen Provoost, Rudi Hendriks, Leen Seys, Smitha Kumar, Tania Maes, Guy Brusselle, Guy Joos
Source:
International Congress 2016 – Immune responses in the lung
Session:
Immune responses in the lung
Session type:
Poster Discussion
Number:
3640
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Katrien De Grove (Ghent, Belgium), Katrien De Grove, Sharen Provoost, Rudi Hendriks, Leen Seys, Smitha Kumar, Tania Maes, Guy Brusselle, Guy Joos. Dysregulation of type 2 innate lymphoid cells and Th2 cells impairs pollutant-induced allergic airway responses. Eur Respir J 2016; 48: Suppl. 60, 3640
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
D-tryptophan influences allergic airway inflammation and Th2 immune responses
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015
The role of IL-17 producing NK cells and other innate immune cells in poly(I:C) triggered exacerbation of experimental asthma
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Nociceptin modulates the inflammatory immune microenvironment in a conventional murine model of asthma
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
Comparing the effects of oxidative stress on mitochondrial function and antiviral responses in primary bronchial epithelial cells of asthmatics and non-asthmatics
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
Farm dust decreases Th2 driven allergic airway inflammation in mice: A role for airway TLR2 and TLR4?
Source: Annual Congress 2011 - T-cell subsets
Year: 2011
Association between T-regulatory cells blood content and Th2 cells activity in asthma
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
Batf3-dependent dendritic cells control house dust mite-driven Th2 and Th17 response through IL-12 production
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
Increased influx of progenitor B cell subsets in the lung with diverse levels of
in-situ
proliferation and activation in a murine model of allergic inflammation
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014
The dynamic change of IL-25 and its receptor expression during allergen challenge in asthmatic subjects
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015
Hyperactivity of the IL33-ST2 axis during postnatal alveolarization increases susceptibility to allergic airway inflammation by enhancing migration and skewing of CD11b+ dendritic cells
Source: International Congress 2015 – More paediatric asthma and allergy
Year: 2015
Peripheral blood Th9 cells and IL-9 level in asthma patients with early and dual asthmatic response
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015
Human mast cells and type 2 innate lymphoid cells activate gene expression and mucus composition in human bronchial epithelial cells via IL-13
Source: International Congress 2014 – Mechanistic studies of the airway epithelium
Year: 2014
IL-37 requires IL18Rα and SIGIRR to diminish experimental allergic airway inflammation in mice
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
Chymase-positive mast cells represent a major source for IL-17A in airway inflammation
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Loss of bronchial epithelial E-cadherin results in spontaneous airway remodeling and eosinophilic inflammation and exaggerated responses to house-dust mite
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015
CD39/CD73 and the imbalance of Th17 and Tregs (regulatory T cells) in allergic asthma
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
TLR-3 triggered exacerbation of experimental asthma depends on IL-17 producing NK cells
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
Imbalance of immune response functional phenotype and alveolar macrophages phenotype in COPD
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
LATE-BREAKING ABSTRACT: IL-5-induced airways eosinophilia as a negative regulator of TLR7 expression may impair the interferon response to rhinovirus in allergic airways
Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Year: 2014
Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept